Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging.

p53 is a key mediator of cellular response to stress, and, although its function has been carefully evaluated in vitro, noninvasive evaluation of the transcriptional activity of p53 in live animals has not been reported. To this end, we developed a transgenic mouse model wherein the firefly luciferase gene expression was dependent on the p53-responsive P2 promoter from the murine double minute 2 (MDM2) gene. Bioluminescence activity following ionizing radiation was shown to be dose, time, and p53 dependent. In addition, expression of both p53 and its activated form as well as the expression of p53 target genes (MDM2 and p21) correlated with bioluminescence activity. Temporal evaluation of p53 activity following ionizing radiation showed a distinct oscillatory pattern, which confirmed the oscillations observed previously in cultured cells. In addition, the kinetics of oscillations were altered by pretreatment with radiation-modifying agents. These results show the use of this mouse model in enhancing our understanding of the transcriptional role of p53 in vivo.

[1]  Francesca Storici,et al.  Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence , 2002, Molecular and Cellular Biology.

[2]  Peng Huang,et al.  The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.

[3]  S. Kern,et al.  High-throughput measurement of the Tp53 response to anticancer drugs and random compounds using a stably integrated Tp53-responsive luciferase reporter. , 2003, Carcinogenesis.

[4]  Vasilis Ntziachristos,et al.  A submillimeter resolution fluorescence molecular imaging system for small animal imaging. , 2003, Medical physics.

[5]  Wafik S El-Deiry,et al.  Bioluminescent Molecular Imaging of Endogenous and Exogenous p53-Mediated Transcription In Vitro and In Vivo Using an HCT116 Human Colon Carcinoma Xenograft Model , 2003, Cancer biology & therapy.

[6]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[7]  Xin Lu,et al.  Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.

[8]  A. Gudkov,et al.  Different impact of p53 and p21 on the radiation response of mouse tissues , 2000, Oncogene.

[9]  G. Stark,et al.  Transgenic mice with p53‐responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo , 1997, The EMBO journal.

[10]  M. Oren,et al.  A functional p53-responsive intronic promoter is contained within the human mdm2 gene. , 1995, Nucleic acids research.

[11]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[12]  John Jeremy Rice,et al.  A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  I. Barash,et al.  Real‐time imaging of β‐lactoglobulin‐targeted luciferase activity in the mammary glands of transgenic mice , 2002, Molecular reproduction and development.

[14]  U Alon,et al.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Dewhirst,et al.  Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. , 2005, International journal of radiation oncology, biology, physics.

[16]  B. Vikram,et al.  Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  G. M. Leclerc,et al.  Development of a destabilized firefly luciferase enzyme for measurement of gene expression. , 2000, BioTechniques.

[18]  S S Gambhir,et al.  Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  C. Mcginn,et al.  The mechanism of action of radiosensitization of conventional chemotherapeutic agents. , 2003, Seminars in radiation oncology.

[20]  A. Gudkov,et al.  The role of p53 in determining sensitivity to radiotherapy , 2003, Nature Reviews Cancer.

[21]  E. Wright,et al.  Tissue‐specific p53 responses to ionizing radiation and their genetic modification: the key to tissue‐specific tumour susceptibility? , 2003, The Journal of pathology.

[22]  Shengyun Fang,et al.  Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.

[23]  M. Hollstein,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.

[24]  G. Wahl,et al.  A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation , 2005, Cell cycle.

[25]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[26]  P. Gruss,et al.  Transgenic mouse model for studying the transcriptional activity of the p53 protein: age‐ and tissue‐dependent changes in radiation‐induced activation during embryogenesis , 1997, The EMBO journal.

[27]  Galit Lahav,et al.  The Strength of Indecisiveness: Oscillatory Behavior for Better Cell Fate Determination , 2004, Science's STKE.

[28]  N. Monk.  Oscillatory Expression of Hes1, p53, and NF-κB Driven by Transcriptional Time Delays , 2003, Current Biology.

[29]  L. Milas,et al.  Radioprotection of mouse jejunum by WR-2721 and WR-1065: effects on DNA strand-break induction and rejoining. , 1988, Radiation research.

[30]  David Piwnica-Worms,et al.  Real-time imaging of ligand-induced IKK activation in intact cells and in living mice , 2005, Nature Methods.

[31]  W. El-Deiry,et al.  Tissue-specific induction of p53 targets in vivo. , 2002, Cancer research.

[32]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[33]  A. Gudkov,et al.  Prospective therapeutic applications of p53 inhibitors. , 2005, Biochemical and biophysical research communications.

[34]  M. E. Perry.  Mdm2 in the response to radiation. , 2004, Molecular cancer research : MCR.

[35]  T. Soussi,et al.  p53 mutation heterogeneity in cancer. , 2005, Biochemical and biophysical research communications.

[36]  R. Leahy,et al.  Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging , 2005, Physics in medicine and biology.

[37]  T. Lawrence,et al.  Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. , 1990, International journal of radiation oncology, biology, physics.

[38]  D. Schaffer,et al.  Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells , 2004, Biotechnology and bioengineering.

[39]  L. Núñez,et al.  Episodic gonadotropin-releasing hormone gene expression revealed by dynamic monitoring of luciferase reporter activity in single, living neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Wyllie,et al.  p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. , 1994, Oncogene.

[41]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[42]  M. E. Perry,et al.  The p53 Tumor Suppressor Protein Does Not Regulate Expression of Its Own Inhibitor, MDM2, Except under Conditions of Stress , 2000, Molecular and Cellular Biology.

[43]  U. Lopes,et al.  p53-dependent Induction of Apoptosis by Proteasome Inhibitors* , 1997, The Journal of Biological Chemistry.

[44]  Andrea Ciliberto,et al.  Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.

[45]  J. Goldblum,et al.  Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice , 2004, Oncogene.

[46]  M. Oren,et al.  Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. , 1993, Oncogene.